Tyra Biosciences, Inc.
TYRA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001863127
In the last 90 days, Tyra Biosciences, Inc. insiders filed 1 open-market purchase and 0 sales; 168 institutions reported holding it in 13F filings for Q2 2026, worth $2.22B in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Tyra Biosciences, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 51
- +5 vs. Q4 2022
- Shares held
- 35.7M
- +414.5K (+1.2%) vs. Q4 2022
- Total value
- $573.0M
- +$305.1M (+113.9%) vs. Q4 2022
- New holders
- 10
- 16 more added
- Sold out
- 5
- 10 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TYRA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 168 | $2.22B |
| Q1 2026 | 164 | $2.52B |
| Q4 2025 | 133 | $1.49B |
| Q3 2025 | 116 | $778.4M |
| Q2 2025 | 121 | $541.5M |
| Q1 2025 | 117 | $499.5M |
| Q4 2024 | 113 | $675.8M |
| Q3 2024 | 95 | $1.11B |
| Q2 2024 | 79 | $748.6M |
| Q1 2024 | 77 | $768.4M |
| Q4 2023 | 62 | $495.2M |
| Q3 2023 | 59 | $502.1M |
| Q2 2023 | 59 | $616.7M |
| Q1 2023 | 51 | $573.0M |
| Q4 2022 | 46 | $267.8M |
| Q3 2022 | 49 | $313.8M |
| Q2 2022 | 48 | $255.6M |
| Q1 2022 | 46 | $386.6M |
| Q4 2021 | 45 | $494.2M |
| Q3 2021 | 26 | $456.8M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Tyra Biosciences, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Nisa Investment Advisors, LLC | 16 | $0 | 0.00% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 54 | $868 | 0.00% | +54 | New |
| The PNC Financial Services Group, Inc. | 58 | $932 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 742 | $12.0K | 0.00% | −2,602−77.8% | Reduced |
| Metropolitan Life Insurance Co | 814 | $13.1K | 0.00% | +814 | New |
| Ameritas Investment Partners, Inc. | 940 | $15.1K | 0.00% | 00.0% | Unchanged |
| Amalgamated Bank | 1,325 | $21.0K | 0.00% | −296−18.3% | Reduced |
| Legal & General Group Plc | 1,405 | $22.6K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,546 | $25.0K | 0.00% | −347−18.3% | Reduced |
| Wells Fargo & Company | 2,362 | $38.0K | 0.00% | +2,362 | New |
| UBS Group AG | 4,619 | $74.2K | 0.00% | +1,032+28.8% | Added |
| California State Teachers Retirement System | 4,930 | $79.2K | 0.00% | −592−10.7% | Reduced |
| American International Group, Inc. | 6,400 | $102.8K | 0.00% | +127+2.0% | Added |
| Barclays PLC | 6,785 | $109.0K | 0.00% | +3,204+89.5% | Added |
| MetLife Investment Management | 7,702 | $123.8K | 0.00% | +7,702 | New |
| Deutsche Bank AG | 8,138 | $130.8K | 0.00% | +3,127+62.4% | Added |
| New York State Common Retirement Fund | 10,525 | $169.1K | 0.00% | 00.0% | Unchanged |
| Sepio Capital, LP | 10,625 | $170.7K | 0.02% | 00.0% | Unchanged |
| Millennium Management LLC | 13,475 | $217.0K | 0.00% | +13,475 | New |
| Morgan Stanley | 15,309 | $246.0K | 0.00% | +4,906+47.2% | Added |
| Bank of America Corp | 18,011 | $289.4K | 0.00% | −2,951−14.1% | Reduced |
| Nuveen Asset Management, LLC | 18,756 | $301.0K | 0.00% | 00.0% | Unchanged |
| LPL Financial LLC | 19,500 | $313.4K | 0.00% | −500−2.5% | Reduced |
| Mariner, LLC | 21,529 | $346.0K | 0.00% | +21,529 | New |
| Rhumbline Advisers | 21,926 | $352.0K | 0.00% | +1,178+5.7% | Added |
| Fishman Jay A Ltd | 22,000 | $353.5K | 0.05% | 00.0% | Unchanged |
| Victory Capital Management Inc | 33,760 | $542.5K | 0.00% | +33,760 | New |
| Bank of New York Mellon Corp | 41,531 | $667.4K | 0.00% | −4,838−10.4% | Reduced |
| Artia Global Partners LP | 45,253 | $727.2K | 0.29% | +45,253 | New |
| Ikarian Capital, LLC | 48,170 | $774.1K | 0.32% | +48,170 | New |
| Wellington Management Group LLP | 84,260 | $1.35M | 0.00% | +6,105+7.8% | Added |
| Logos Global Management LP | 87,673 | $1.41M | 0.20% | −23,183−20.9% | Reduced |
| Charles Schwab Investment Management Inc | 102,370 | $1.65M | 0.00% | +3,867+3.9% | Added |
| Northern Trust Corp | 107,542 | $1.73M | 0.00% | +1,775+1.7% | Added |
| Driehaus Capital Management LLC | 134,173 | $2.16M | 0.03% | +134,173 | New |
| JPMorgan Chase & Co | 192,509 | $3.09M | 0.00% | −6,698−3.4% | Reduced |
| State Street Corp | 232,089 | $3.73M | 0.00% | +15,463+7.1% | Added |
| Geode Capital Management, LLC | 286,104 | $4.60M | 0.00% | +32,412+12.8% | Added |
| Woodline Partners LP | 410,435 | $6.60M | 0.09% | +111,419+37.3% | Added |
| Perceptive Advisors LLC | 494,403 | $7.95M | 0.24% | 00.0% | Unchanged |
| Vanguard Group Inc | 639,324 | $10.3M | 0.00% | +34,957+5.8% | Added |
| BlackRock Inc. | 666,885 | $10.7M | 0.00% | +11,794+1.8% | Added |
| Fairmount Funds Management LLC | 1,416,998 | $22.8M | 3.92% | 00.0% | Unchanged |
| Frazier Life Sciences Management, L.P. | 1,421,310 | $22.8M | 1.65% | +93,645+7.1% | Added |
| TCG Crossover Management, LLC | 1,989,103 | $32.0M | 6.23% | 00.0% | Unchanged |
| Nextech Invest AG | 2,518,582 | $40.5M | 16.89% | 00.0% | Unchanged |
| FMR LLC | 3,147,987 | $50.6M | 0.00% | −731,136−18.8% | Reduced |
| BVF Inc | 3,239,595 | $52.1M | 1.90% | +767,268+31.0% | Added |
| Canaan Partners XI LLC | 4,409,991 | $70.9M | 50.98% | 00.0% | Unchanged |
| Boxer Capital, LLC | 6,448,359 | $103.6M | 5.09% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 7,236,454 | $116.3M | 2.63% | 00.0% | Unchanged |
| Sio Capital Management, LLC | 0 | $0 | 0.00% | −152,159−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −33,005−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −26,717−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −89−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −1−100.0% | Sold out |